145 related articles for article (PubMed ID: 38816520)
1. Spirituality is associated with immune parameters and disease activity in primary Sjögren's syndrome: a cross-sectional study.
Módis LV; Aradi Z; Horváth IF; Pikó P; Papp G; Osváth M; Szántó A; Bugán A
Sci Rep; 2024 May; 14(1):12473. PubMed ID: 38816520
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmune interactions in Sjögren's syndrome: relationship of exocrine gland dysfunction with autoantibodies to muscarinic acetylcholine receptor-3 and mental health status parameters.
Deák M; Szvetnik A; Balog A; Sohár N; Varga R; Pokorny G; Tóth G; Kiss M; Kovács L
Neuroimmunomodulation; 2013; 20(2):79-86. PubMed ID: 23235351
[TBL] [Abstract][Full Text] [Related]
3. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
4. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
5. Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides.
Karaiskos D; Mavragani CP; Sinno MH; Déchelotte P; Zintzaras E; Skopouli FN; Fetissov SO; Moutsopoulos HM
Rheumatology (Oxford); 2010 Sep; 49(9):1762-9. PubMed ID: 20525741
[TBL] [Abstract][Full Text] [Related]
6. Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study.
Cui Y; Xia L; Li L; Zhao Q; Chen S; Gu Z
BMC Psychiatry; 2018 May; 18(1):131. PubMed ID: 29769121
[TBL] [Abstract][Full Text] [Related]
7. Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.
Kotsis K; Voulgari PV; Tsifetaki N; Drosos AA; Carvalho AF; Hyphantis T
Rheumatol Int; 2014 Dec; 34(12):1671-81. PubMed ID: 24769916
[TBL] [Abstract][Full Text] [Related]
8. Targeting primary Sjögren's syndrome.
Odani T; Chiorini JA
Mod Rheumatol; 2019 Jan; 29(1):70-86. PubMed ID: 30424703
[TBL] [Abstract][Full Text] [Related]
9. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
Lauvsnes MB; Tjensvoll AB; Maroni SS; Kvivik I; Grimstad T; Greve OJ; Harboe E; Gøransson LG; Putterman C; Omdal R
Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
[TBL] [Abstract][Full Text] [Related]
10. Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjögren's syndrome.
Sariyildiz A; Coskun Benlidayi I; Yetişir A; Turk I; Zengin Acemoglu SS; Deniz V
Clin Rheumatol; 2024 Jun; 43(6):1949-1958. PubMed ID: 38691249
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
13. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
14. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
16. Personality, depression and anxiety in primary Sjogren's syndrome - Association with sociodemographic factors and comorbidity.
Milic V; Grujic M; Barisic J; Marinkovic-Eric J; Duisin D; Cirkovic A; Damjanov N
PLoS One; 2019; 14(1):e0210466. PubMed ID: 30653543
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren's syndrome.
Cui Y; Li J; Li L; Zhao Q; Chen S; Xia L; Fu T; Ji J; Gu Z
Int J Rheum Dis; 2020 Mar; 23(3):367-373. PubMed ID: 31763772
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
Front Immunol; 2019; 10():2096. PubMed ID: 31552042
[TBL] [Abstract][Full Text] [Related]
19. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
